drug price
-
First floor
Pfizer, Roche and Johnson & Johnson are the leaders of the global pharmaceutical industry
Pfizer, Roche and Johnson & Johnson account for 12.6% of the total value of the pharmaceutical industry worldwide, driven by the increase…
Leggi » -
First floor
Price of medicines: a reply to the Director of AIFA. With the fetish of transparency, the hedging difficulties of a State with delusions of omnipotence are unloaded on the sector
The medicines market is heavily regulated. Even before some specific strategies to contain pharmaceutical expenditure, such as…
Leggi » -
News
Drug price. AIFA: Without transparency there can be no real competition.
Because Italy and Trump will vivisection drug prices. AIFA's word On medicines we are faced with an information asymmetry that…
Leggi » -
News
Aifa: "There must be no lack of information on drug shortages"
Rome, February 4 - The problem of drug shortages? It is not, nor can it be, a problem of lack of…
Leggi » -
News
United States: parties united in asking the pharmaceutical industry to lower prices: the time for uncontrolled increases in drug prices is over
Washington, Jan 30 00:55 - (Nova Agency) - The members of the US Congress of the two political parties communicated to…
Leggi » -
News
Chiazzese (M5S): what does the government intend to do to increase the sales of generic drugs? Minister Grillo: "strengthening information to increase its use" Editor's note
For information, we report the question below Oral answer question 3-00175 presented by CHIAZZESE Giuseppe Tuesday 18 September 2018, session…
Leggi » -
News
USA. Investors in Big Pharma are demanding higher profits. The financial limits of biotechnology and the pitfalls of generics
Big Pharma Tackles Curse of Billionaire Blockbuster Investors Demand Today's Extraordinarily Lucrative Drugs Have a…
Leggi » -
News
Pharma 4.0, halfway through
In the production and R&D of drug companies, the digital transformation has reached even higher levels than in…
Leggi » -
News
There is also a shortage of medicines in Switzerland
Shortages for some medicines Stocks at the limit also in Swiss hospital pharmacies. Alarm, among others, for the EpiPen, used…
Leggi » -
First floor
Doctors' conflict of interest with Big Pharma. Ed
Pharmaceutical companies that bankroll doctors. In exchange for the prescription of their drugs. A survey published in the British Medical Journal Open analyzes…
Leggi »